Stay updated on Tepotinib Phase II Clinical Trial
Sign up to get notified when there's something new on the Tepotinib Phase II Clinical Trial page.

Latest updates to the Tepotinib Phase II Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter revision label updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedFooter Revision updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check28 days agoChange DetectedShows a new 'Show glossary' option and minor typographic updates in the Study Record Dates area, including capitalization changes in 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new 'Revision: v3.4.0' label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check35 days agoChange DetectedThe Study Record Dates section now displays 'Last Update Posted' as a standalone item, replacing the previous 'Last Update Posted (Estimated)' label.SummaryDifference0.0%

- Check42 days agoChange DetectedFooter revision updated to v3.3.4 (replacing v3.3.3). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange DetectedThe Study Record Dates section now shows 'Last Update Posted (Estimated)' instead of 'Last Update Posted'. This is a metadata clarification that does not alter the study details or how users interact with the page.SummaryDifference0.0%

Stay in the know with updates to Tepotinib Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tepotinib Phase II Clinical Trial page.